Minkowski Awardees:

2022 Stockholm
M. Heni (DE): The insulin resistant brain: impact on whole-body metabolism and body fat distribution

2021 Virtual Meeting
A. Bonnefond (FR): Hunt for rare variants and pretty little things in the genetics of diabetes

2020 Virtual Meeting
G.P. Fadini (IT): Should I stay or should I go? The bone marrow and stem cell traffic in diabetes

2019 Barcelona
F.K. Knop (DK): My gut feeling about glucagon

2018 Berlin
F. Bäckhed (SE): The gut microbiota - a forgotten organ - that contributes to glucose metabolism

2017 Lisbon
E.R. Pearson (UK): Targeting therapy in diabetes: insights from genetics

2016 Munich
P. Schrauwen (NL): Let's energise: mitochondria and energy turnover to comBAT type 2 diabetes

2015 Stockholm
M. Blüher (DE): Size, sites and cytes: importance of adipose tissue in diabetes and beyond

2014 Vienna
A. Gloyn (UK): Unravelling causal mechanisms in diabetes pathogenesis

2013 Barcelona
M. Cnop (BE): The heart of the matter: beta cells in diabetes

2012 Berlin
T.M. Frayling (UK): Human genetics and type 2 diabetes: behind the headlines

2011 Lisbon
N. Sattar (UK): Exploiting biomarkers and large datasets for insights into diabetes and cardiovascular disease

2010 Stockholm
F. Gribble (UK): Molecular mechanisms underlying the secretion of incretin hormones

2009 Vienna
G. Perseghin (IT): Ectopic fat: the result of the interaction between insulin resistance and energy metabolism

2008 Rome
J.C. Brüning (DE): Insulin action in the central nervous system: from metabolism to neurodegeneration and control of lifespan

2007 Amsterdam
M. Stoffel (CH): Transcriptional control of metabolism in type 2 diabetes: Lessons learned from fasting and feeding

2006 Copenhagen
M. Roden (DE): From overabundance to energy crisis

2005 Athens
P. Rossing (DK): Progression of diabetic nephropathy: Prediction, promotion, prevention - and the pill

2004 Munich
G.A. Rutter (UK): Orchestrating insulin secretion at the single vesicle level

2003 Paris
M. Stumvoll (DE): Control of glycemia - from molecules to men

2002 Budapest
B.O. Roep (NL): T-cells in the pathogenesis of type 1 diabetes: The good, the bad and the ugly

2001 Glasgow
J.R. Zierath (SE): Insulin signalling and glucose transport in sketal muscle: Unravelling the mysteries of metabolic disease

2000 Jerusalem
H. Edlund (SE): Factors controlling beta-cell identity and glucose homeostasis

1999 Brussels
R. Scharfmann (FR): Control of early development of the pancreas in rodent and human

1998 Barcelona
J.H. Auwerx (FR): PPARγ, a versatile metabolic regulator

1997 Helsinki
P. Froguel (FR): Genetics of type 2 diabetes: Back to the future

1996 Vienna
P. Rorsman (DK): The pancreatic beta-cell as a fuel sensor: An electrophysiologist's view point

1995 Stockholm
J. Todd (UK): The genetics of type I diabetes: It was only a nightmare

1994 Düsseldorf
T. Mandrup Poulson (DK): The role of interleukin-1 in the pathogenesis of insulin dependent diabetes dellitus

1993 Istanbul
H. Yki-Järvinen (FI): Insulin action in heart, muscle and liver - from pathophysiology towards optimal therapy

1992 Prague
E. van Schaftingen (BE): Glycolysis revisited

1991 Dublin
C. Boitard (FR): The differentiation of the immune system towards anti-islet immunity. Clinical prospects

1990 Copenhagen
P. Halban (CH): Proinsulin trafficking and processing

1989 Lisbon
H.-U. Häring (DE): The insulin receptor kinase: Its role in insulin action and in the pathogenesis of type 2 (non-insulin-dependent) diabetes

1988 Paris
J.C. Hutton (UK): The insulin secretory Granule

1987 Leipzig
J.-L. Carpentier (CH): The cell biology of the insulin receptor interaction

1986 Rome
D. Pipeleers (BE): Biosociology of the pancreatic beta-cell

1985 Madrid
E. Van Obberghen (FR): Insulin receptor: from hormone recognition to cell activation

1984 London
A. Lernmark (DK): Molecular biology of insulin dependant diabetes

1983 Oslo
S.L. Howell (UK): The mechanism of insulin secretion

1982 Budapest
G.F. Bottazzo (UK): B-cell damage: Are we approaching the solution?

1981 Amsterdam
P. De Meyts (BE): The multiple affinity States of the insulin receptor and their physiological implication

1980 Athens
I.-B. Taljedal (SE): On insulin secretion

1979 Vienna
S.J. Ashcroft (UK): Glucoreceptor mechanisms and the control of insulin release and biosynthesis

1978 Zagreb
J. Nerup (DK): HLA factors and autoimmunity in insulin-dependant diabetics

1977 Geneva
J. Wahren (SE): Physical exercise and fuel homeostasis in diabetes mellitus

1976 Helsinki
K.D. Hepp (DE): Studies on the mechanism of insulin action: Basic concepts and clinical implications

1975 Munich
P. Freychet (FR): Interactions of polypeptide hormones with cell membrane specific receptors: Studies with insulin and glucagon

1974 Jerusalem
E. Cerasi (SE): Mechanisms of glucose stimulated insulin secretion in health and in diabetes: Some re-evaluations and proposals

1973 Brussels
L. Orci (IT/CH): A portrait of the pancreatic beta-cell

1972 Madrid
W.J. Malaisse (BE): Insulin secretion: multifactorial regulation for a single process of release

1971 Southampton
C.N. Hales (UK): Immunological techniques in diabetes research

1970 Warsaw
B. Jeanrenaud (CH): Adipocytes, available energy and endocrine pancreas

1969 Montpellier
B. Hellman (SE): Methodological approaches to studies on the pancreatic islets

1968 Louvain
L.A. Carlson (SE): Antilipolysis as a tool in the study of clinical and experimental diabetes

1967 Stockholm
E.R. Froesch (CH): The physiology and pharmacology of adipose tissue lipolysis: Its inhibition and implications for the treatment of diabetes

1966 Aarhus
P.J. Randle (UK): Carbohydrate metabolism and lipid storage and break-down in diabetes